HIGHLIGHTS
- who: Line Bechsgaard Andersen and colleagues from the Faculty of Health, University of Southern Denmark, Odense, Denmark have published the research work: The Clinical Impact of Methylated Homeobox A9 ctDNA in Patients with Non-Resectable Biliary Tract Cancer Treated with Erlotinib and Bevacizumab, in the Journal: Cancers 2022, 4598 of /2022/
- what: The aim was to investigate the association with survival of meth-HOXA9 in late-stage BTC patients treated with erlotinib and bevacizumab and to describe the effect and adverse events of the treatment. Most of the patients in this study had undergone one . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.